NCT04495036

Brief Summary

This study is to investigate the current use and intention to use of teledermatology in Swiss dermatology patients, dermatologists, other physicians and medical staff.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
683

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 2019

Shorter than P25 for all trials

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2019

Completed
7 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 31, 2020

Completed
6 months until next milestone

First Submitted

Initial submission to the registry

July 28, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2020

Completed
Last Updated

August 4, 2020

Status Verified

August 1, 2020

Enrollment Period

7 months

First QC Date

July 28, 2020

Last Update Submit

August 3, 2020

Conditions

Keywords

TeledermatologyTelemedicine

Outcome Measures

Primary Outcomes (2)

  • descriptive analysis: deviation in influencing factors for the acceptance of teledermatology

    Assessment of the deviation in influencing factors for the acceptance of teledermatology (subjective disease perception versus objective assessment by physicians)

    at baseline

  • descriptive analysis of the impact of medical education for the acceptance of telemedicine among dermatologists vs. other physicians vs. medical staff vs. patients

    Comparison of the impact of medical education for the acceptance of telemedicine among dermatologists vs. other physicians vs. medical staff vs. patients

    at baseline

Study Arms (2)

dermatology patients

Other: data collection (21-items-patient descriptive survey)

physicians and medical staff

Other: data collection (23-items-physician descriptive survey)

Interventions

Dermatology patients are asked to complete a 21-items-survey while waiting for the doctor's consultation. Following variables will be addressed: * Demographic data of telemedicine users and non-users * Subjective disease perception of the dermatology patients * Use of internet, telemedicine and telemedicine insurance model * Patients´ willingness for additional features of telemedicine * Advantages and disadvantages telemedicine and face-to-face consultation * Suitable fields of dermatology for telemedicine from the patient's perspective * Recommended structure of telemedical services by users and non-users

dermatology patients

To obtain the view of Swiss dermatologists, other physicians and medical staff on telemedicine a 23-items-survey will be completed. Following variables will be addressed: * Objective disease perception of the treating dermatologist (regarding the urgency of the patient's medical examination, the functional impairment and cosmetic burden due to patient's disease, the impairment of life quality due to patient's disease and the estimation of the course of the patient's disease) * Suitable fields of dermatology for telemedicine from the physician's and medical staff's perspective

physicians and medical staff

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients treated in the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich and Dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich.

You may qualify if:

  • patients treated in the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich
  • dermatologists, other physicians and medical staff of the Department of Dermatology of the Cantonal Hospital Aarau and the University Hospitals Basel and Zürich

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Kantonsspital Aarau

Aarau, 5001, Switzerland

Location

Department of Dermatology, University Hospital Basel

Basel, 4031, Switzerland

Location

University Hospital Zürich

Zurich, 8091, Switzerland

Location

Related Publications (1)

  • Maul LV, Jahn AS, Pamplona GSP, Streit M, Gantenbein L, Muller S, Nielsen ML, Greis C, Navarini AA, Maul JT. Acceptance of Telemedicine Compared to In-Person Consultation From the Providers' and Users' Perspectives: Multicenter, Cross-Sectional Study in Dermatology. JMIR Dermatol. 2023 Aug 11;6:e45384. doi: 10.2196/45384.

MeSH Terms

Conditions

Skin Diseases

Interventions

Data Collection

Condition Hierarchy (Ancestors)

Skin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

Epidemiologic MethodsInvestigative TechniquesHealth Care Evaluation MechanismsQuality of Health CareHealth Care Quality, Access, and EvaluationPublic HealthEnvironment and Public Health

Study Officials

  • Lara Valeska Maul, Dr. med.

    Department of Dermatology, University Hospital Basel

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2020

First Posted

July 31, 2020

Study Start

July 1, 2019

Primary Completion

January 31, 2020

Study Completion

January 31, 2020

Last Updated

August 4, 2020

Record last verified: 2020-08

Locations